Double-blind, placebo-controlled evaluation of biorest liposomal alendronate in diabetic patients undergoing PCI: The BLADE-PCI trial

Généreux, P., Chernin, G., Assali, A. R., Peruga, J. Z., Robinson, S. D., Schampaert, E., Bagur, R., Mansour, S., Rodés-Cabau, J., McEntegart, M., Gerber, R., L’Allier, P., de Silva, R., Daneault, B., Aggarwal, S. K., Džavík, V., Ozan, M. O., Ben-Yehuda, O., Maehara, A., … Jonas, M. (2022). Double-blind, placebo-controlled evaluation of biorest liposomal alendronate in diabetic patients undergoing PCI: The BLADE-PCI trial. American Heart Journal, 249, 45–56. https://doi.org/10.1016/j.ahj.2022.03.004
Authors:
Philippe Généreux
Gil Chernin
Abid R. Assali
Jan Z. Peruga
Simon D. Robinson
Erick Schampaert
Rodrigo Bagur
Samer Mansour
Josep Rodés-Cabau
Margaret McEntegart
Robert Gerber
Philippe L'Allier
Ranil de Silva
Benoit Daneault
Suneil K. Aggarwal
Vladimír Džavík
M. Ozgu Ozan
Ori Ben-Yehuda
Akiko Maehara
Gregg W. Stone
Michael Jonas
Affiliated Authors:
Ori Ben-Yehuda
Akiko Maehara
Publication Type:
Article
Unique ID:
10.1016/j.ahj.2022.03.004
PMID:
Publication Date:
Data Source:
Scopus

Record Created: